More epilepsy medicines linked to birth defects if taken during pregnancy
Several epilepsy medicines carry risks when taken in pregnancy, a review, published today by the Medicines and Healthcare products Regulatory Agency (MHRA), has found.
Stories about risks
People with epilepsy at slightly increased risk of more severe COVID-19 symptoms, study suggests
There is a slightly increased risk of hospital admission and death from COVID-19 in people with epilepsy, according to a new study in the British Medical Journal (BMJ).
The research, published in October 2020, looked at risk factors for hospital admissions and death from COVID-19 in 6.08 million adults across England. The data were collected between 24 January and 30 April.
New safety measures around sodium valproate endorsed by European medicines regulatory body
New measures to avoid valproate exposure of babies during pregnancy have been backed by medicines regulatory body CMDh.
